ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Clinical trials for ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE explained in plain language.
Never miss a new study
Get alerted when new ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE trials appear
Sign up with your email to follow new studies for ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested in kids with Tough-to-Treat leukemia
Disease control Recruiting nowThis early-stage study aims to find the safest and most effective dose of a drug called venetoclax when given alongside standard chemotherapy. It is for children, teens, and young adults up to age 40 with high-risk blood cancers like leukemia and myelodysplastic syndrome (MDS) th…
Matched conditions: ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Phase: PHASE1 • Sponsor: Andrew E. Place, MD • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for tough blood cancers: scientists test supercharged cord blood transplants
Disease control Recruiting nowThis study is testing a refined procedure for umbilical cord blood transplants in adults and children with high-risk blood cancers like leukemia and lymphoma. The goal is to see if this optimized approach improves survival and reduces complications compared to standard transplant…
Matched conditions: ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New transplant technique aims to stop Body's attack on itself in kids with cancer
Disease control Recruiting nowThis study is testing whether removing a specific type of immune cell (called naive T cells) from a donor's stem cells before transplant can prevent chronic graft-versus-host disease in children and young adults with blood cancers. Chronic graft-versus-host disease is a serious c…
Matched conditions: ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for babies: testing powerful drug combos against rare leukemia
Disease control Recruiting nowThis study is testing whether adding two newer drugs, blinatumomab and venetoclax, to standard chemotherapy works better for babies under one year old with a rare and aggressive type of blood cancer called acute lymphoblastic leukemia (ALL). The main goal is to see if these combi…
Matched conditions: ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope pill aims to stop Leukemia's return after transplant
Disease control Recruiting nowThis study is testing a new oral drug called revumenib to see if it can safely help prevent certain aggressive types of leukemia from coming back after a patient has received a stem cell transplant. The trial will enroll about 27 patients, including children as young as 2, who ha…
Matched conditions: ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for Tough-to-Treat leukemia: first patients test novel drug
Disease control Recruiting nowThis is the first time a new drug called ziftomenib is being tested in people. The study aims to find a safe and effective dose for adults with advanced acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL) that has returned or not responded to other treatments. It w…
Matched conditions: ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Phase: PHASE1, PHASE2 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New pill targets Tough-to-Treat blood cancers in major trial
Disease control Recruiting nowThis study is testing a new oral medication called revumenib for people with acute leukemias that have come back or not responded to standard treatments. The first part of the study aims to find the safest and most effective dose. The second part will test how well the drug works…
Matched conditions: ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Phase: PHASE1, PHASE2 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Hope for youngest leukemia patients: new drug combo enters first safety trial
Disease control Recruiting nowThis study is testing whether adding a new drug called revumenib to two standard chemotherapy drugs is safe and effective for children and young adults with acute myeloid leukemia (AML) that has come back or hasn't responded to previous treatment. The main goal is to find the saf…
Matched conditions: ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New hope for rare, Tough-to-Treat leukemia
Disease control Recruiting nowThis study is testing whether a combination of two drugs, venetoclax and azacitidine, can help people newly diagnosed with a rare and aggressive type of blood cancer called acute leukemia of ambiguous lineage. The goal is to see if this drug combo can put the cancer into remissio…
Matched conditions: ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Phase: PHASE2 • Sponsor: Sheng-Li Xue, MD • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Faster transplant strategy aims to cut risks for older blood cancer patients
Disease control Recruiting nowThis study is testing a new, faster treatment plan for adults aged 60 and older with aggressive blood cancers like acute myeloid leukemia (AML). The goal is to see if giving strong chemotherapy followed quickly by a lower-intensity stem cell transplant is safer and more effective…
Matched conditions: ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC